Skip to content

Neogen NEOG Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$5.24B+84.4%
Agilent Technologies logo
Agilent TechnologiesA
$0
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$12.6M
Phibro Animal Health logo
Phibro Animal HealthPAHC
$350M
Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN
$2.11B+2,307%
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$2B+93.1%
Enterprise value$2.63B+45.5%
P/S2.3×+1.1×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Reported directly by Neogen in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfLongTermDebt.

The official record: Neogen’s 10-K, filed July 30, 2025, on SEC EDGAR. View the filing →

Ask your AI about Neogen's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neogen's debt issuance proceeds?
Neogen (NEOG) reported debt issuance proceeds of $112.5M in Q1 2025.
What does debt issuance proceeds mean?
Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.